Who We Are
How can we do more for our patients?
Everything at Takeda starts with this question.
Positions & Guidelines
Risk & Crisis Management
From the CEO
We have global presence in more than 70 countries.
What We Do
Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.
Research & Development
Takeda Clinical Trial Transparency
Publications of Takeda Research Laboratories
Investigator Initiated Sponsored Research
Alliances & Partnerships
Access to Medicines
Supplier Code of Conduct
Pharmaceutical Supply Chain Initiative
Supplier Qualification & Due Diligence
We focus on our core therapeutic areas.
Find out Takeda's stories related on Innovation, Caring and Heritage
Quality at Takeda
The Key Elements at the Heart of Our Innovation
Medicine for the World
Safeguarding Plant Diversity
Takeda at TICAD
Going Beyond Medicines
Change the World
An Empowered Women-led Workforce
Keys to Aging Gracefully
Takeda is committed to creating corporate value by developing outstanding pharmaceutical products and conducting corporate citizenship activities.
Basic Policies on CSR
Corporate Citizenship Activities
Global CSR Program
Global Relay for Life
Digital Birth Program
Corporate Citizenship Videos
CSR Data Book
CSR Data Book Survey
Takeda is working to resolve global healthcare issues with people around the world.
Last 12 months
July 27, 2017
Jul 27, 2017
TESARO AND TAKEDA ENTER INTO EXCLUSIVE LICENSING AGREEMENT TO DEVELOP AND COMMERCIALIZE NOVEL CANCER THERAPY NIRAPARIB IN JAPAN
July 27, 2017
Jul 27, 2017
Takeda selected by major index and sustainability rating institutions concerning Corporate Social Responsibility (CSR)
July 26, 2017
Jul 26, 2017
TAKEDA AND BIOSURFACES ANNOUNCE JOINT RESEARCH PROGRAM TO EXPLORE PROMISING DEVICES TO TREAT GASTROINTESTINAL DISEASES
July 21, 2017
Jul 21, 2017
Takeda and Schrödinger Announce Multi-year, Multi-Target Research Collaboration
July 11, 2017
Jul 11, 2017
Takeda prices US$500 million senior note offering
July 10, 2017
Jul 10, 2017
Takeda Announces Start-up of its Wholly-owned Subsidiary at Shonan Research Center which Supports Drug Discovery to Drive Innovation
June 30, 2017
Jun 30, 2017
Takeda Announces Selection of Global CSR Programs Emphasizing Prevention for Health in Developing and Emerging Countries
June 29, 2017
Jun 29, 2017
Takeda Submits a New Drug Application for Rasagiline Mesylate for the Treatment of Parkinson’s Disease in Japan
Copyright 1995-2017 Takeda Pharmaceutical Company Limited. All rights reserved.